ORAMED PHARMACEUTICALS INC. Nonoperating Income (Expense)
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-10
- ORAMED PHARMACEUTICALS INC. nonoperating income (expense) for the quarter ending 2026-06-30 was $103.74M, a 575.15% increase year-over-year.
- ORAMED PHARMACEUTICALS INC. nonoperating income (expense) for the quarter ending 2026-03-31 was $44.85M.
- ORAMED PHARMACEUTICALS INC. nonoperating income (expense) for the quarter ending 2025-12-31 was $15.18M.
- ORAMED PHARMACEUTICALS INC. nonoperating income (expense) for the quarter ending 2025-09-30 was $61.47M.
- ORAMED PHARMACEUTICALS INC. nonoperating income (expense) for fiscal 2025 was $89.45M.
- ORAMED PHARMACEUTICALS INC. nonoperating income (expense) for fiscal 2024 was -$2.29M, a 109.99% decline from fiscal 2023.
- ORAMED PHARMACEUTICALS INC. nonoperating income (expense) for fiscal 2023 was $22.89M, a 680.30% increase from fiscal 2022.
- ORAMED PHARMACEUTICALS INC. nonoperating income (expense) for fiscal 2022 was $2.93M.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $103.74M 10-Q · filed 2026-08-10 | $148.59M 10-Q · filed 2026-08-10 | $163.77M derived: sum of 3 quarters · filed 2026-08-10 | $225.24M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $44.85M 10-Q · filed 2026-05-19 | $60.02M derived: sum of 2 quarters · filed 2026-05-19 | $121.50M derived: sum of 3 quarters · filed 2026-05-19 | $136.86M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $15.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $76.65M derived: sum of 2 quarters · filed 2026-03-26 | $92.01M derived: sum of 3 quarters · filed 2026-08-10 | $89.45M 10-K · filed 2026-03-26 |
| 2025-09-30 | $61.47M 10-Q · filed 2025-11-13 | $76.84M derived: sum of 2 quarters · filed 2026-08-10 | $74.28M 10-Q · filed 2025-11-13 | $68.09M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $15.37M 10-Q · filed 2026-08-10 | $12.81M 10-Q · filed 2026-08-10 | $6.62M derived: sum of 3 quarters · filed 2026-08-10 | -$8.80M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$2.56M 10-Q · filed 2026-05-19 | -$8.75M derived: sum of 2 quarters · filed 2026-05-19 | -$24.17M derived: sum of 3 quarters · filed 2026-05-19 | -$9.93M derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-12-31 | -$6.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$21.61M derived: sum of 2 quarters · filed 2026-03-26 | -$7.37M derived: sum of 3 quarters · filed 2026-03-26 | -$2.29M 10-K · filed 2026-03-26 |
| 2024-09-30 | -$15.42M 10-Q · filed 2025-11-13 | -$1.19M derived: sum of 2 quarters · filed 2025-11-13 | $3.90M 10-Q · filed 2025-11-13 | $22.29M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $14.23M 10-Q · filed 2025-08-14 | $19.32M 10-Q · filed 2025-08-14 | $37.71M derived: sum of 3 quarters · filed 2025-08-14 | $38.14M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $5.09M 10-Q · filed 2025-05-15 | $23.47M derived: sum of 2 quarters · filed 2025-05-15 | $23.91M derived: sum of 3 quarters · filed 2025-05-15 | $26.39M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $18.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $18.82M derived: sum of 2 quarters · filed 2025-03-27 | $21.30M derived: sum of 3 quarters · filed 2025-03-27 | $22.89M 10-K · filed 2025-03-27 |
| 2023-09-30 | $435.00K 10-Q · filed 2024-11-07 | $2.91M derived: sum of 2 quarters · filed 2024-11-07 | $4.51M 10-Q · filed 2024-11-07 | $5.51M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $2.48M 10-Q · filed 2024-08-14 | $4.08M 10-Q · filed 2024-08-14 | $5.08M derived: sum of 3 quarters · filed 2024-08-14 | $6.12M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $1.60M 10-Q · filed 2024-05-09 | $2.60M derived: sum of 2 quarters · filed 2024-05-09 | $3.64M derived: sum of 3 quarters · filed 2024-05-09 | |
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $2.04M derived: sum of 2 quarters · filed 2024-03-06 | $2.93M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $1.04M 10-Q · filed 2023-11-09 | $1.93M 10-Q · filed 2023-11-09 |